The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-10B (GB-10) as 10B-carriers for boron neutron capture therapy

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 5, 2006, Pages 1515-1522

  Masunaga, Shin ichiro ^a   Kasaoka, Satoshi ^b   Maruyama, Kazuo ^c   Nigg, David ^d   Sakurai, Yoshinori ^e   Nagata, Kenji ^a   Suzuki, Minoru ^a   Kinashi, Yuko ^a   Maruhashi, Akira ^a   Ono, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d IDAHO NATIONAL LABORATORY   (United States)

^e SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Boron neutron capture therapy; BSH; GB 10; Quiescent cell; Transferrin pendant type polyethyleneglycol liposome

Indexed keywords

CELLS; POLYETHYLENE GLYCOLS; RADIOTHERAPY;

BORON NEUTRON CAPTURE THERAPY; BSH; GB-10; LIPOSOMES; NEUTRON CAPTURE; QUIESCENT CELL; TRANSFERRIN-PENDANT-TYPE POLYETHYLENEGLYCOL LIPOSOME;

LIPIDS;

BORON 10; BROXURIDINE; DECAHYDRODECABORATE B 10; DRUG CARRIER; LIPOSOME; MACROGOL; RADIOISOTOPE; SODIUM BOROCAPTATE B 10; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL KILLING; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENCAPSULATION; FEMALE; GAMMA SPECTROMETRY; IMMUNOFLUORESCENCE; MICRONUCLEUS TEST; MOUSE; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SOLID TUMOR;

ANIMALS; BOROHYDRIDES; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; DRUG CARRIERS; LIPOSOMES; MICE; MICRONUCLEUS TESTS; POLYETHYLENE GLYCOLS; SULFHYDRYL COMPOUNDS; TRANSFERRIN;

EID: 33751196368     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.08.028     Document Type: Article

References (21)

1. Barth R.F., Coderre J.A., Vicente M.G., et al. Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 11 (2005) 3987-4002
2. Wu G., Barth R.F., Yang W., et al. Boron containing macromolecules as nanovehicles as delivery agents for neutron capture therapy. Anti-Cancer Agents Med Chem 6 (2006) 167-184
3. Yanagie H., Tomita T., Kobayashi H., et al. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br J Cancer 75 (1997) 660-665
4. Ishida O., Maruyama K., Sasaki K., et al. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 190 (1999) 49-56
5. Maruyama K., Ishida O., Kasaoka S., et al. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Cont Release 98 (2004) 195-335
6. Trivillin V.A., Heber E.M., Nigg D.W., et al. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: A new paradigm in BNCT radiobiology. Radiat Res 166 (2006) 387-396
7. Stelzer K.J., Gavin P.R., Risler R., et al. Boron neutron capture-enhanced fast neutron therapy (BNC/FNT) for non-small cell lung cancer in canine patients. In: Hawthorne M.F. (Ed). Frontiers in neutron capture therapy (2001), Kluwer Academic/Plenum Publishers, New York 735-739
8. 10 (GB-10) in human tumor patients. In: Monduzzi E. (Ed). Research and development in neutron capture therapy (2002), Litosei-Rastignano, Bologna, Italy 993-999 Proceedings of the 10th International Congress on Neutron Capture Therapy
9. Masunaga S., and Ono K. Significance of the response of quiescent cell populations within solid tumors in cancer therapy. J Radiat Res 43 (2002) 11-25
10. Maruyama K., Takizawa T., Yuda T., et al. Targetability of novel immunoliposomes modified with amphipathic polyethyleneglycols conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta 1234 (1995) 74-80
11. Szoka F., and Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75 (1978) 4194-4198
12. Ishida K., Maruyama H., Tanahashi M., et al. Liposomes bearing polyethyleneglycol coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm Res 18 (2001) 1042-1048
13. Dautry-Varsat A., Ciechanover A., and Lodish H. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 80 (1983) 2258-2262
14. 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry. Nucl Instrum Methods 204 (1983) 525-531
15. Caswell R.S., Coyne J.J., and Randolph M.L. Kerma factors for neutron energies below 30 MeV. Radiat Res 83 (1980) 217-254
16. Sakurai Y., and Kobayashi T. Characteristics of the KUR heavy water neutron irradiation facility as a neutron irradiation field with variable energy spectra. Nucl Instr Meth Phys Res A 453 (2000) 569-596
17. Wagner E., Curiel D., and Cotton M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv Drug Deliv Rev 14 (1994) 113-135
18. Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 5 (1999) 443-451
19. Masunaga S., Ono K., Sakurai Y., et al. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios. Int J Radiat Oncol Biol Phys 41 (1998) 1163-1170
20. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14 (2004) 198-206
21. Koumenis C., Alarcon R., Hammond E., et al. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 21 (2001) 1297-1310